Clinical Trial Update: Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal microbiota transplantation for diarrhea-predominant irritable bowel syndrome has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Montefiore Medical Center | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2019-07-02